Literature DB >> 20033192

Imiquimod induces apoptosis of human melanocytes.

Chul-Ho Kim1, Joo Hee Ahn, Sung Un Kang, Hye Sook Hwang, Mi Hye Lee, Jung Hee Pyun, Hee Young Kang.   

Abstract

Development of vitiligo-like hypopigmentary lesions associated with topical imiquimod has been reported. We hypothesized that mode of action of imiquimod in melanocytes may include triggering of apoptosis resulted in loss of cells, which may be a possible mechanism of imiquimod-induced hypopigmentary lesions. Therefore, we investigated whether imiquimod induces apoptosis of human melanocytes and also whether it modulates expression of apoptosis-related molecules in human melanocytes. Imiquimod treatment induced apoptosis of melanocytes, which was observed by TUNEL assay and Hoechst 33258 staining. Imiquimod-induced apoptosis was further shown by measuring mitochondrial membrane potential in melanocytes. The apoptotic activity of imiquimod was associated with caspase-3, Bcl-2 and mitogen-activated protein kinase expression in melanocytes. These results indicated that imiquimod induces apoptosis of melanocytes. These findings may provide a clue to understand pathogenesis of imiquimod-induced vitiligo-like hypopigmentary lesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20033192     DOI: 10.1007/s00403-009-1012-0

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  10 in total

1.  Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo.

Authors:  Kirsten C Webb; Jonathan M Eby; Vidhya Hariharan; Claudia Hernandez; Rosalie M Luiten; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2014-07-10       Impact factor: 3.960

2.  Development of Vitiligo-Like Depigmentation after Treatment of Lentigo Maligna Melanoma with 5% Imiquimod Cream.

Authors:  Na Hee Kim; Jee Bum Lee; Sook Jung Yun
Journal:  Ann Dermatol       Date:  2018-06-28       Impact factor: 1.444

3.  Therapy with transcutaneous administration of imiquimod combined with oral administration of sorafenib suppresses renal cell carcinoma growing in an orthotopic mouse model.

Authors:  Takashi Karashima; Keiko Udaka; Mayumi Niimura; Katsuhide Suzuki; Hiroto Osakabe; Tsutomu Shimamoto; Satoshi Fukata; Keiji Inoue; Naoto Kuroda; Motoharu Seiki; Taro Shuin
Journal:  Oncol Lett       Date:  2017-05-24       Impact factor: 2.967

4.  Uterine epithelial cells specifically induce interferon-stimulated genes in response to polyinosinic-polycytidylic acid independently of estradiol.

Authors:  Mickey V Patel; Mimi Ghosh; John V Fahey; Charles R Wira
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

5.  TLR9 and RIG-I signaling in human endocervical epithelial cells modulates inflammatory responses of macrophages and dendritic cells in vitro.

Authors:  Ameya Sathe; Kudumula Venkata Rami Reddy
Journal:  PLoS One       Date:  2014-01-07       Impact factor: 3.240

6.  Induction of vitiligo after imiquimod treatment of condylomata acuminata.

Authors:  Wenfei Li; Hongyan Xin; Lingzhi Ge; Haiyan Song; Wang Cao
Journal:  BMC Infect Dis       Date:  2014-06-13       Impact factor: 3.090

7.  Vulvar vitiligo-like depigmentation and multiple halos of hypomelanosis at the trunk following treatment with imiquimod 5% cream for vulvar condylomata: casual or related events?

Authors:  Maíra Chiarelli Serra; Claudia Menicanti; Elisabetta Pennacchioli; Giulio Tosti
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

8.  Vitiligo or Vitiligo-like Hypopigmentation Associated with Imiquimod Treatment of Condyloma Acuminatum: Not a Casual Event.

Authors:  Fu-Quan Long; Li-Shi Zhao; Yi-Hong Qian
Journal:  Chin Med J (Engl)       Date:  2017-02-20       Impact factor: 2.628

Review 9.  Melanogenesis Connection with Innate Immunity and Toll-Like Receptors.

Authors:  Saaya Koike; Kenshi Yamasaki
Journal:  Int J Mol Sci       Date:  2020-12-21       Impact factor: 5.923

10.  Imiquimod induced vitiligo-like lesions-A consequence of modified melanocyte function.

Authors:  Haiyan Yu; Jianping Cen; Xiaoxia Lin; Hao Cheng; Oliver Seifert
Journal:  Immun Inflamm Dis       Date:  2021-10-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.